Metabolic response of Escherichia coli to subinhibitory concentration of ofloxacin


Creative Commons License

KOÇAK E., ÖZKUL KOÇAK C.

JOURNAL OF RESEARCH IN PHARMACY, cilt.24, sa.4, ss.593-601, 2020 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.35333/jrp.2020.207
  • Dergi Adı: JOURNAL OF RESEARCH IN PHARMACY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.593-601
  • Anahtar Kelimeler: Metabolomics, antibiotic resistance, GC/MS, MS-DIAL, TCA cycle, TRANSCRIPTOMIC ANALYSES, ANTIBIOTIC-RESISTANCE, GLUTATHIONE, REVEALS, OMICS
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Antibiotic resistance is one of the most important problems worldwide. In order to overcome antibiotic resistance, pathogen-antibiotic interactions should be investigated at molecular level. In our present study, we focused on metabolic differences in Escherichia coli (E. coli) under ofloxacin stress to understand adaptation and resistance mechanisms. We used GC/MS based metabolomics approach for metabolite identification and quantification. Experimental results showed that 17 metabolites were altered under subinhibitory concentration of ofloxacin. Pathway analysis indicated that TCA cycle, glyoxylate and dicarboxylate metabolism, biosynthesis of fatty acids, glutathione metabolism were induced by ofloxacin. Moreover, we evaluated metabolites individually and we found that spermine and L-ascorbic acid increased in ofloxacin treated groups. These metabolites are important in resistance and detoxifying processes in cells. In conclusion, altered metabolome profile gave information on adaptation and resistance processes in E. coli against ofloxacin. These metabolic changes will help to enlighten resistance mechanisms and discover novel treatment strategies against the pathogens.